Bright Minds Biosciences Inc. · CSE:DRUG
Point72 Asset Management, L.P.'s stake in Bright Minds Biosciences Inc. fell to 3.00% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Point72 Asset Management, L.P.'s stake in Bright Minds Biosciences Inc. fell to 3.00%, 135,189 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 3.00%
- Shares
- 135,189
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 3.00% | 135,189 |
| Point72 Capital Advisors, Inc. | 3.00% | 135,189 |
| Steven A. Cohen | 3.00% | 135,189 |
Source
Related
- Bright Minds Biosciences Inc.
- Point72 Asset Management, L.P.
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026